Dr. Monohan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
800 Rose Street
CC404 Roach Bldg. Uk Hematology Clinic
Lexington, KY 40536Phone+1 859-257-6006Fax+1 859-257-6002- Is this information wrong?
Summary
- Dr. Gregory Monohan is an oncologist in Lexington, KY and is affiliated with University of Kentucky Albert B. Chandler Hospital. He received his medical degree from University of Kentucky College of Medicine and has been in practice 17 years. He specializes in hematologic oncology and is experienced in hematologic oncology and stem cell transplantation.
Education & Training
University of Kentucky College of MedicineFellowship, Hematology and Medical Oncology, 2003 - 2006
Indiana University School of MedicineResidency, Internal Medicine, 2000 - 2003
University of Kentucky College of MedicineClass of 2000
Certifications & Licensure
KY State Medical License 2003 - 2025- American Board of Internal Medicine Hematology
Clinical Trials
- Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702) Start of enrollment: 2010 May 01
Publications & Presentations
PubMed
- 3 citationsPerformance status, comorbidities, and cycles of methotrexate exert the greatest influence on outcomes of primary and secondary CNS lymphomas: the Lexington experience.Lauren D Curry, Reinhold Munker, Ning Li, Donglin Yan, Paul Pryor, Sahar Nozad, Patrick Keller, Gregory P Monohan, Chaitanya Iragavarapu, Maxwell M Krem> ;Annals of Hematology. 2023 Jan 1
- Treatment-Associated Acute Lymphoblastic Leukemia Following Autologous Hematopoietic Stem Cell Transplant and Lenalidomide Maintenance in Patients With Multiple Myeloma.James Crosby, Tosha Erzuah, Mahvish Haider, Forrest Smith, Shyam Ganti, Gregory Monohan, Raymond Elsouiedi> ;Journal of Investigative Medicine High Impact Case Reports. 2022 Oct 27
- 1 citationsAge Adjusted Comorbidity Risk Index Does Not Predict Outcomes in an Autologous Hematopoietic Stem Cell Transplant Population.Dylan Barth, Michael Singleton, Gregory Monohan, Brian McClune, Val Adams> ;Cell Transplantation. 2022 Feb 28
- Join now to see all
Journal Articles
- Age Adjusted Hematopoietic Stem Cell Transplant Comorbidity Index Predicts Survival in a T-cell Depleted Cohort☆Swati Yalamanchi, Hayder Saeed, Dianna Howard, Gerhard C Hildebrandt, Roger Herzig, Gregory Monohan, ScienceDirect
- Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/vincristine in Relapsed/refractory Aggressive B-cell LymphomaDaniel Persky, Soham Puvvada, Catherine Spier, Gregory Monohan, Ari VanderWalde, Daruka Mahadevan, Clinical Cancer Research
Professional Memberships
- Member
Hospital Affiliations
University of Kentucky Albert B. Chandler HospitalLexington, Kentucky
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
